Texas Permanent School Fund’s Vir Biotechnology VIR Stock Holding History

Texas Permanent School Fund’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-74,977	Closed	-$760K	–	1364
2024 Q1	$760K	Buy	74,977 +1,012	+1%	+$10.3K	0.01%	1381
2023 Q4	$744K	Buy	73,965 +1,440	+2%	+$13.2K	0.01%	1381
2023 Q3	$680K	Buy	72,525 +5,285	+8%	+$75.4K	0.01%	1367
2023 Q2	$1.65M	Sell	67,240 -806	-1%	-$20.2K	0.02%	1075
2023 Q1	$1.58M	Buy	68,046 +17,035	+33%	+$436K	0.02%	1063
2022 Q4	$1.29M	Sell	51,011 -3,364	-6%	-$82.5K	0.02%	994
2022 Q3	$1.05M	Buy	54,375 +795	+1%	+$20.2K	0.02%	1077
2022 Q2	$1.36M	Buy	+53,580	New	+$1.25M	0.02%	970

Other funds holding VIR

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Texas Permanent School Fund's VIR Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Vir Biotechnology (VIR) in Q2 2024, closing a stake of 74,977 shares — an estimated $760K sold.

Texas Permanent School Fund first reported a position in VIR in Q2 2022 and held it in 8 quarters. The position peaked at $1.65M in Q2 2023. 215 funds tracked by Wall St. Rank hold VIR as of Q2 2024.

Texas Permanent School Fund reported no remaining Vir Biotechnology position as of Q2 2024 after selling out during the quarter.
Texas Permanent School Fund sold 74,977 Vir Biotechnology shares in Q2 2024, an estimated $760K.
Texas Permanent School Fund first reported a position in Vir Biotechnology in Q2 2022 and held it in 8 quarters.
Texas Permanent School Fund's Vir Biotechnology position peaked at $1.65M in Q2 2023.
215 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.